[Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report].
In a 7 year old female poodle an adrenocortical tumor was diagnosed on basis of laboratory and ultrasonographic examinations. One year after adrenalectomy, a relapse was diagnosed, at that time the suspicion of metastases in the liver arose for the first time. By treatment with Mitotane in a dose aiming at completely destroying the adrenal cortex, a complete disappearance of the tumor as well as a dramatic reduction of the size of the metastases could be achieved. 12 months after the begin of the chemotherapy, the dog is in good general condition.
Keiser
M
M
Klinik für Kleintiermedizin, Fakultät Zürich.
Flückiger
M
M
Gardelle
O
O
Reusch
C
C
D000306:Adrenal Cortex Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000662:veterinary*; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary / Q000662:veterinary*; D003480:Cushing Syndrome / Q000209:etiology / Q000662:veterinary; D004283:Dog Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D008113:Liver Neoplasms / Q000556:secondary; D008939:Mitotane / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000662:veterinary*; D014463:Ultrasonography
D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane
Mitotane-Behandlung bei einem Hund mit einem rezidivierenden Nebennierenrindenkarzinom--ein Fallbericht.